Clinical trial
Rh-PDGF Versus Emdogain for Treatment of Intra-bony Defects
NCT05442034 is registered in ClinicalTrials.gov with Nova Southeastern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rh-PDGF Versus Emdogain for Treatment of Intra-bony Defects
- Lead sponsor
- Nova Southeastern University
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- January 1, 2023
- Completion date
- June 30, 2027
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intrabony periodontal defect